Contents related with AMD
Dr. Jordi Monés speaks at the EURETINA 2016 Congress about therapeutic approaches to atrophic AMD
Restoring certain types of blindness will be possible over the next decade
A Swine Model of Selective Geographic Atrophy of Outer Retinal Layers Mimicking Atrophic AMD: A Phase I Escalating Dose of Subretinal Sodium Iodate
Fetal transplant - Pilot phase II clinical trial to evaluate the safety of human foetal retinal transplant in the treatment of geographic atrophy secondary to age-related macular degeneration and retinitis pigmentosa
The EYE-RISK European project, a pathway for distinguishing between atrophic AMD patients and personalising their treatment
DARK - Deterioration of the dark adaptation function in patients with drusen.
Eye-Risk - Exploring the combined role of genetic and non-genetic factors that lead to AMD: a system-level analysis of disease subgroups, risk factors and pathways
LITE - Integrated Use of Second Harmonic Generation (SHG) Microscopy to Image Corneal Collagen Fibrils and Adaptive Optics Scanning Laser Ophthalmoscopy (AOSLO) to Image the Photoreceptors.
PRO4VIP - Innovative procurement for visually impaired people
A phase I escalating dose of subretinal sodium iodate: a toxininduced animal model of geographic atrophy of rpe and photoreceptors
GA Characterization - GA Characterization of geographic atrophy progression in patients with age-related macular degeneration: evolution and risk factors associated with geographic atrophy progression (GAIN)
Research is the only solution for the future to fight against blindness
It is only with your help that we can fight against blindness
Collaborate